TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation - Wikidata - wikimedia - TriplyDB

TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation

TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation

http://www.wikidata.org/entity/Q35540023

about

A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in Mice CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis.Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-β1 VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.Modulation of anti-tumor necrosis factor alpha (TNF-α) antibody secretion in mice immunized with TNF-α kinoid A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis.Active immunization with human interleukin-15 induces neutralizing antibodies in non-human primates.Development of a Recombinant Xenogeneic Tumor Necrosis Factor Alpha Protein Vaccine To Protect Mice from Experimental Colitis.Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys.Immunochemical termination of self-tolerance Anticytokine therapy in neuropathic pain management.IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model Vaccination with cytokines in autoimmune diseases.Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.Emerging applications of anticytokine vaccines.IL-1 Vaccination Is Suitable for Treating Inflammatory Diseases.Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis.Arthritis models: usefulness and interpretation.Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels.Characterization of a novel anti-human TNF-alpha murine monoclonal antibody with high binding affinity and neutralizing activity.Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis.Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis.Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.Tumor Necrosis Factor-Alpha Targeting Can Protect against Arthritis with Low Sensitization to Infection.Aldehyde modification and alum coadjuvancy enhance anti-TNF-α autovaccination and mitigate arthritis in rat.BMP-7 inhibits cartilage degeneration through suppression of inflammation in rat zymosan-induced arthritis.

P2860

Q28554288-9DF33332-8300-412B-87CD-E6FC4827AEF1 Q30388433-26BDDC10-DF38-4FAF-A538-586FD4CBCE37 Q34170097-C92E3B93-3AD1-40D4-9BE4-71675416AF75 Q34413235-6FFFFDD1-8B91-48A7-8D1B-628EEA8BD5DE Q34724711-83CC064B-6373-40EB-BF63-0C9E052DC775 Q35070050-AC2DF51D-DB0B-4CFB-AC12-9E6F640DEDC9 Q35635564-B35950C5-CAEC-4F64-94EE-D337BBFF3E3E Q35940690-32FC3BD9-E9D8-4343-A0F1-7745618118CE Q36099992-207E2B23-BE84-4E0C-85F1-9FC7890E7A02 Q36145575-3DD66677-3CD2-4F9A-AA27-CF2575B7B73E Q36316797-E816A6F4-5BD1-4A90-9F84-DAD07C436A5D Q36499879-70FDE9ED-66EA-41C2-9C65-88B83F012F20 Q36837408-5E6DE773-B398-49E6-9310-B3EA268DE2A2 Q36998861-DEBD9B78-7EB2-4908-A2D5-9F827CC3B905 Q37125180-ED4E068E-B05D-463A-8258-ECA37CF3DC9A Q37165366-8F856D74-1953-49BF-AEF1-7EA2FAECB721 Q37270803-0918ABCF-6D29-44BB-B2E5-CDC65C27D3EA Q37340457-0D070FA3-B412-4CFB-BCAB-B2D01A0A15CC Q37614491-76DA8AD9-BF21-4D1D-9163-24CBECCC8590 Q37773243-71EE63AD-3855-4690-AE2B-20920FED5C62 Q37773295-7E02D1E9-71CA-4FA3-962D-18D5ADB725CE Q37850806-9830C11C-9FF7-4514-8192-D55F16ACB632 Q38872112-CCA70E7F-2E54-4945-9A21-AC2DE362EC06 Q39453656-7DD85F33-9986-402F-8AC6-4ED3AD48B930 Q40008198-62EDEA75-8DA9-428E-AC3B-72DA42BF9BDC Q40485583-4E8A5484-89F9-439B-B2CA-E021C732F592 Q43238854-2C4A01BE-9FBD-46D0-A045-9031F8580D4B Q45069341-2D680602-8204-4849-961D-7D771E197735 Q45929497-6E567020-8140-4394-B56F-105A31FE1112 Q47571231-3A182CEF-BEAF-4512-AE3E-5133BE3200DF Q53254708-E94FE8E9-D17F-479D-ACE1-7E22F10E5207

P2860

TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation

http://www.wikidata.org/entity/Q35540023

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

TNFalpha kinoid vaccination-in ...... chronic and acute inflammation

@ast

TNFalpha kinoid vaccination-in ...... chronic and acute inflammation

@en

type

label

TNFalpha kinoid vaccination-in ...... chronic and acute inflammation

@ast

TNFalpha kinoid vaccination-in ...... chronic and acute inflammation

@en

prefLabel

TNFalpha kinoid vaccination-in ...... chronic and acute inflammation

@ast

TNFalpha kinoid vaccination-in ...... chronic and acute inflammation

@en

P1433

Q35540023-442B8EED-8E97-4AE8-8F15-35634D040383

P1476

Q35540023-656D2E64-9988-4E64-A5FE-C3A9F27E1814

P2093

Q35540023-06821AAA-4C4F-4812-8454-A704B366C1C9

Q35540023-55F6686B-0B85-45C7-878F-8BC2E0349A76

Q35540023-5CCC2EF7-9E57-4C62-A711-E77F8424BA17

Q35540023-9A331B74-B03F-4B44-97D7-012220B5198C

Q35540023-AB3B3489-EF51-46AB-A5D3-6CCB544FC2AB

Q35540023-F1DC424C-CFB7-4A2F-9678-CC50067720F5

Q35540023-F353540E-98E4-4648-B418-1D36AC472BDC

P2860

Q35540023-2F53F892-BE22-4758-B078-482D5830CE0E

Q35540023-3319E7B2-CF54-400B-8065-0460DCB5721E

Q35540023-3382B355-156B-4321-9822-EF8A87B97E2B

Q35540023-39AD176B-B9CD-4A6E-BDED-DAE3872F8CE1

Q35540023-3A859DB1-10A1-4A8A-A8F0-AD286F997ABE

Q35540023-3B517DFE-DC5F-4712-8A77-4759CDF60F06

Q35540023-3E116F2A-2467-4279-AA5E-6F9237D5AC08

Q35540023-3F3CFE8A-2852-45F4-B493-624BA215424C

Q35540023-41DB731D-290A-4338-956B-573BAA91CDAE

Q35540023-4BD4A45D-4791-4131-B728-234B11442D07

P304

Q35540023-07DEA467-0CBC-4E20-9DC9-3F2C2205BD84

P31

Q35540023-46D8370A-1093-48D2-BBEB-449EACA094C9

P356

Q35540023-C9392432-B6DF-4486-B70E-9857EBEA5563

P407

Q35540023-C6D4C42A-8364-4554-9E86-71C37EB41DA5

P433

Q35540023-EF7E97FA-F835-4E47-A540-76B1B5EF7039

P478

Q35540023-5D145771-19C6-4C38-9D1F-EDBC5E1A521A

P50

Q35540023-5ED609EB-147E-4F5D-950A-D15267ABF6B7

Q35540023-7975C2B5-06C4-4B06-81BB-6AA1A14ED231

Q35540023-BC777C77-1004-43B5-9F6A-48E9A8AB4038

P577

Q35540023-51DF5678-4D4E-4640-A894-2BF06EB6DAC6

P5875

Q35540023-7B8B6AF2-C2C8-49BE-8B06-95C2B5011915

P698

Q35540023-054418CE-CAFC-4594-8816-95DB2B80D102

P921

Q35540023-8603267F-7A41-4CA1-AA66-A6F13559465D

P932

Q35540023-1F8E355E-7466-4CDF-A1E1-E8602137B895

P356

PNAS.0604827103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

TNFalpha kinoid vaccination-in ...... chronic and acute inflammation

@en

P2093

Bernard Bizzini

http://www.w3.org/2001/XMLSchema#string

Daniel Zagury

http://www.w3.org/2001/XMLSchema#string

Hélène Le Buanec

http://www.w3.org/2001/XMLSchema#string

Laure Delavallée

http://www.w3.org/2001/XMLSchema#string

Marie-Christophe Boissier

http://www.w3.org/2001/XMLSchema#string

Natacha Bessis

http://www.w3.org/2001/XMLSchema#string

Sébastien Paturance

http://www.w3.org/2001/XMLSchema#string

P2860

The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study

Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody.

P304

19442-19447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0604827103

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Hélène Le Buanec

P577

2006-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6640504

http://www.w3.org/2001/XMLSchema#string

P698

17158801

http://www.w3.org/2001/XMLSchema#string

P921

P932

1748245

http://www.w3.org/2001/XMLSchema#string